BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9183118)

  • 1. Pregnancy outcome and neurodevelopment of children exposed in utero to psychoactive drugs: the Motherisk experience.
    Loebstein R; Koren G
    J Psychiatry Neurosci; 1997 May; 22(3):192-6. PubMed ID: 9183118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurodevelopment of adopted children exposed in utero to cocaine.
    Nulman I; Rovet J; Altmann D; Bradley C; Einarson T; Koren G
    CMAJ; 1994 Dec; 151(11):1591-7. PubMed ID: 7954158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-year outcome of children exposed prenatally to drugs.
    Griffith DR; Azuma SD; Chasnoff IJ
    J Am Acad Child Adolesc Psychiatry; 1994 Jan; 33(1):20-7. PubMed ID: 7511139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodevelopmental effects of prenatal exposure to psychotropic medications.
    Gentile S
    Depress Anxiety; 2010 Jul; 27(7):675-86. PubMed ID: 20583298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurodevelopment of adopted children exposed in utero to cocaine: the Toronto Adoption Study.
    Nulman I; Rovet J; Greenbaum R; Loebstein M; Wolpin J; Pace-Asciak P; Koren G
    Clin Invest Med; 2001 Jun; 24(3):129-37. PubMed ID: 11437064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy.
    Scolnik D; Nulman I; Rovet J; Gladstone D; Czuchta D; Gardner HA; Gladstone R; Ashby P; Weksberg R; Einarson T
    JAMA; 1994 Mar; 271(10):767-70. PubMed ID: 7509419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Children exposed to valproate in utero--population based evaluation of risks and confounding factors for long-term neurocognitive development.
    Eriksson K; Viinikainen K; Mönkkönen A; Aikiä M; Nieminen P; Heinonen S; Kälviäinen R
    Epilepsy Res; 2005 Jul; 65(3):189-200. PubMed ID: 16029946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor and mental development of infants exposed to antiepileptic drugs in utero.
    Thomas SV; Ajaykumar B; Sindhu K; Nair MK; George B; Sarma PS
    Epilepsy Behav; 2008 Jul; 13(1):229-36. PubMed ID: 18346940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of psychiatric drugs in pregnancy and lactation.
    Arnon J; Shechtman S; Ornoy A
    Isr J Psychiatry Relat Sci; 2000; 37(3):205-22. PubMed ID: 11084808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal outcome following pregnancy exposure to antidepressants: a prospective controlled cohort study.
    Maschi S; Clavenna A; Campi R; Schiavetti B; Bernat M; Bonati M
    BJOG; 2008 Jan; 115(2):283-9. PubMed ID: 17903222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating the neurocognitive effects of an early intervention program for children with prenatal alcohol exposure.
    Yazdani P; Motz M; Koren G
    Can J Clin Pharmacol; 2009; 16(3):e453-9. PubMed ID: 19934465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C; Polard E; Mauduit N; Allain H
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term neurodevelopmental risks in children exposed in utero to cocaine. The Toronto Adoption Study.
    Koren G; Nulman I; Rovet J; Greenbaum R; Loebstein M; Einarson T
    Ann N Y Acad Sci; 1998 Jun; 846():306-13. PubMed ID: 9668417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Course of psychiatric disorders in pregnancy. Dilemmas in pharmacologic management.
    Altshuler LL; Szuba MP
    Neurol Clin; 1994 Aug; 12(3):613-35. PubMed ID: 7990794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive functioning in children prenatally exposed to alcohol and psychotropic drugs.
    Dalen K; Bruarøy S; Wentzel-Larsen T; Laegreid LM
    Neuropediatrics; 2009 Aug; 40(4):162-7. PubMed ID: 20135573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obstetric and neonatal effects of drugs of abuse.
    Levy M; Koren G
    Emerg Med Clin North Am; 1990 Aug; 8(3):633-52. PubMed ID: 2201525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Toronto experience in diagnosing alcohol-related neurodevelopmental disorder: a unique profile of deficits and assets.
    Greenbaum R; Nulman I; Rovet J; Koren G
    Can J Clin Pharmacol; 2002; 9(4):215-25. PubMed ID: 12584580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Child neurodevelopmental outcome and maternal occupational exposure to solvents.
    Laslo-Baker D; Barrera M; Knittel-Keren D; Kozer E; Wolpin J; Khattak S; Hackman R; Rovet J; Koren G
    Arch Pediatr Adolesc Med; 2004 Oct; 158(10):956-61. PubMed ID: 15466682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodevelopmental and neurobehavioral sequelae of selected substances of abuse and psychiatric medications in utero.
    Walker A; Rosenberg M; Balaban-Gil K
    Child Adolesc Psychiatr Clin N Am; 1999 Oct; 8(4):845-67. PubMed ID: 10553207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological correlates of fetal cocaine exposure.
    Chiriboga CA
    Ann N Y Acad Sci; 1998 Jun; 846():109-25. PubMed ID: 9668401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.